Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients

BACKGROUND: After successful of antiretroviral therapy, highly effective direct acting antiviral (DAA) make HCV elimination reasonable in HIV/HCV co-infected patients. However, in achieving this target, there are still barriers to start DAA treatment, particularly in the area of liver fibrosis asses...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Infect Dis
Päätekijät: Yunihastuti, Evy, Wicaksana, Bramantya, Wiraguna, Andrian, Hidayah, Ainum Jhariah, Amelia, Fhadilla, Natali, Veritea, Widhani, Alvina, Sulaiman, Andri Sanityoso, Kurniawan, Juferdy
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7249442/
https://ncbi.nlm.nih.gov/pubmed/32450844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05069-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia